OVID - Wall Street Estimates - Ovid Therapeutics Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.5

2.04 %

$ 35.5 M

Market Cap

-1.35

P/E

Price Target Average

1366.67%

Revenue Forecast Estimate

260.33%

EBIT Estimate

55.72%

Net Income Estimate

--4.52%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Ovid Therapeutics Inc.

Wall Street analysts predict an average 1-year price target for OVID of $7.33 , with forecasts ranging from a low of $3 to a high of $11 .

OVID Lowest Price Target Wall Street Target

3 USD 500.00%

OVID Average Price Target Wall Street Target

7.33 USD 1366.67%

OVID Highest Price Target Wall Street Target

11 USD 2100.00%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free